Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
This program supports research aimed at advancing the understanding and treatment of Prader-Willi syndrome (PWS) and Schaaf-Yang syndrome (SYS), with a particular interest in projects that could lead to new interventions to alleviate symptoms associated with these conditions.
Característiques principals
FPWR priority areas include:
  • Genotype to phenotype: understanding PWS genetics and how loss of PWS-critical region genes leads to the phenotype
  • Neurobiology of hunger, feeding behavior and metabolism in PWS
  • Neurobiology of cognition, maladaptive behavior and mental health in PWS
  • Clinical care research: evaluation of existing drugs and interventions to improve significant clinical concerns in PWS
  • Therapeutics development for PWS: genetic therapies, novel or repurposed pharmaceuticals, and devices
  • Lloc de presentació
    HMRIB and PSMAR staff who need more information should contact:
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.: 1670
    Marta López: [email protected] Ext.: 1576
    Júlia Vidal: [email protected] Ext.: 1736
    Convocatòria (URL)
    https://www.fpwr.org/grant-program
    Informació addicional
    All LOIs and applications must be submitted online through ProposalCentral.
    Requisits
  • Applications are accepted from academic, government, non-profit and for-profit research entities.
  • Academic research applicants must hold a primary faculty appointment at the level of Instructor or higher.
  • The program is intended for junior faculty in the early stages of their careers, established investigators from other research areas wishing to enter the field of PWS or SYS research, or investigators in these fields seeking support for pilot studies in a new area of PWS or SYS research.
  • Innovative, high-risk/high-reward research at an early stage is particularly encouraged.
  • Dotació
    $150,000
    Durada
    18 months, with the possibility of a second 18-month funding period through competitive renewal.

    Arxius

    Arxiu
    PRFAQ1534.pdf